RNS Number : 0989J
Alumasc Group PLC
07 April 2020
The Alumasc Group plc
(the "Company")
7 April 2020
Purchase of Shares
The Company announces that it received notification on 7 April 2020 that Helen Ashton a PDMR, purchased 3,500 shares at 66p.
The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the transactions.
For further details, please contact:
Helen Ashton, Group Company Secretary: 01536 383812
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
|
1.
|
Details of the person discharging managerial responsibilities / person closely associated
|
|
a.
|
Name
|
Helen Ashton
|
|
2.
|
Reason for the notification
|
|
a.
|
Position/status
|
PDMR
|
|
b.
|
Initial notification
/Amendment
|
Initial notification
|
|
3.
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a.
|
Name
|
The Alumasc Group plc
|
|
b.
|
LEI
|
2138002MV11VKZFJ4359
|
|
4.
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a.
|
Description of the
Financial instrument, type
of instrument
Identification code
|
Ordinary 12.5p shares
GB0000280353
|
|
b.
|
Nature of the transaction
|
Purchase of shares
|
|
c.
|
Price(s) and volume(s)
|
Purchases
|
Price(s)
|
Volume(s)
|
|
66p
|
3,500
|
|
|
d.
|
Aggregated information
·
Aggregated volume
·
Price
|
3,500 ordinary 12.5p shares - 66p per share
|
|
e.
|
Date of the transaction
|
2020-04-07
|
|
f.
|
Place of the transaction
|
London Stock Exchange, Main Market (XLON)
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHSSAFDWESSEEL